SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 134 filers reported holding SAGE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,164,000 | +25.5% | 105,000 | +33.5% | 6.27% | +30.3% |
| Q1 2016 | $2,521,000 | -45.0% | 78,641 | 0.0% | 4.81% | -36.9% |
| Q4 2015 | $4,585,000 | +15.6% | 78,641 | -16.1% | 7.62% | -2.5% |
| Q3 2015 | $3,967,000 | -14.7% | 93,741 | +47.1% | 7.81% | +32.7% |
| Q2 2015 | $4,653,000 | +659.1% | 63,741 | +422.7% | 5.89% | +413.3% |
| Q1 2015 | $613,000 | – | 12,195 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |